It's loser not looser.
Yes, but you damn with faint praise.
I don't think this is just a fight for survival although that is in the background.
It's important to recognise what's changed and why the current and ongoing reform of the FDA is so pivotal to what happens next for MSB.
As @dyode says, we are at an inflection point.
Ann: Information For Retail Shareholders, page-306
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 94.0¢ | $551.8K | 579.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 68321 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 54215 | 51 |
View Market Depth
| Last trade - 11.59am 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |